肥胖性肌肉萎缩的分子机制研究进展

doi:10.3969/j.issn.1006-9771.2017.05.013

Abstract

Abstract: Obesity is becoming a chronic epidemic worldwide. Persistent obesity, in addition to triggering changes in skeletal muscle function and structure, may also lead to the occurrence of skeletal muscle atrophy, that maybe associate with autophagy and ubiquitin proteasome, interleukin-6, leptin, adiponectin, interleukin-10, tumor necrosis factor-alpha, growth hormone, angiotensin II, glucocorticoid, advanced glycation end-product and myostatin, etc.

Key words: obesity, muscle atrophy, signal pathway, review

CLC Number:

R589.2

LUO Lin, YANG Jin-peng, WANG Song-tao, LIAO Xin, ZHAN Wei. Advances of Molecular Mechanisms on Obesity Inducing Muscle Atrophy (review)[J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2017, 23(5): 553-557.

References

[1] Egerman MA, Glass DJ. Signaling pathways controlling skeletal muscle mass [J]. Crit Rev Biochem Mol Biol, 2014, 49(10): 59-68.
[2] Sala D, Ivanova S, Plana N, et al. Autophagy-regulating TP53INP2 mediates muscle wasting and is repressed in diabetes [J]. J Clin Invest, 2014, 124(5): 1914-1927.
[3] Cohen S, Nathan JA, Goldberg AL. Muscle wasting in disease: molecular mechanisms and promising therapies [J]. Nat Rev Drug Discov, 2015, 14(1): 58-74.
[4] De Larichaudy J, Zufferli A, Serra F, et al. TNF-α- and tumor-induced skeletal muscle atrophy involves sphingolipid metabolism [J]. Skelet Muscle, 2012, 2(1): 2.
[5] Patel R, Williams DJ, Cummins C. Mini review: new molecular mediators of glucocorticoid receptor activity in metabolic tissues [J]. Mol Endocrinol, 2014, 28(7): 999-1011.
[6] Kim RY, Yang HJ, Song YM, et al. Estrogen modulates bone morphogenetic protein-induced sclerostin expression through the Wnt signaling pathway [J]. Tissue Eng, 2015, 21(13-14): 2076-2088.
[7] Pelosi M, De Rossi M, Barberi L, et al. IL-6 impairs myogenic differentiation by downmodulation of p90RSK/eEF2 and mTOR/p70S6K axes, without affecting AKT activity [J]. BioMed Res, 2014, 2014: 206026.
[8] Schiaffino S, Mammucari C. Regulation of skeletal muscle growth by the IGF-1-Akt/PKB pathway: insights from genetic models [J]. Skelet Muscle, 2011, 1(4): 14.
[9] Babenko NA, Kharchenko VS. Modulation of insulin sensitivity of hepatocytes by the pharmacological downregulation of phospholipase [J]. Int J Endocrinol, 2015, 2015: 794838.
[10] Wang H, Liu D, Cao P, et al. Atrogin-1 affects muscle protein synthesis and degradation when energy metabolism is impaired by the antidiabetes drug berberine [J]. Diabetes, 2010, 59(8): 1879-1889.
[11] Goldman S, Zhang Y, Jin S. Autophagy and adipogenesis. Implications in obesity and type II diabetes [J]. Autophagy, 2010, 6(1): 179-181.
[12] Ezaki JM, Matsumoto N, Takeda-Ezaki M, et al. Liver autophagy contributes to the maintenance of blood glucose and amino acid levels [J]. Autophagy, 2011, 7(7): 727-736.
[13] O'Neill BT, Lauritzen HP, Hirshman MF, et al. Differential role of insulin/IGF-1 receptor signaling in muscle growth and glucose homeostasis [J]. Cell Rep, 2015, 11(8): 1220-1235.
[14] Schiaffino S, Dyar KA, Ciciliot S, et al. Mechanisms regulating skeletal muscle growth and atrophy [J]. FEBS J, 2013, 280(17): 4294-4314.
[15] Akhmedov D, Berdeaux R. The effects of obesity on skeletal muscle regeneration [J]. Front Physiol, 2013, 4: 371.
[16] Rodriguez A, Becerril S, Méndez-Giménez L, et al. Leptin administration activates irisin-induced myogenesis via nitric oxide-dependent mechanisms, but reduces its effect on subcutaneous fat browning in mice [J]. Int J Obes, 2015, 39(3): 397-407.
[17] Arounleut P, Bowser M, Upadhyay S, et al. Absence of functional leptin receptor isoforms in the POUND (Lepr(db/lb)) mouse is associated with muscle atrophy and altered myoblast proliferation and differentiation [J]. PLoS One, 2013, 14: e72330.
[18] MacKenzie MG, Hamilton D, Pepin M, et al. Inhibition of myostatin signaling through Notch activation following acute resistance exercise [J]. PLoS One, 2013, 8: e68743.
[19] Carson JA, Baltgalvis KA. Interleukin 6 as a key regulator of muscle mass during cachexia [J]. Exerc Sport Sci Rev, 2010, 38(4): 168-176.
[20] Sindhu S, Thomas R, Shihab P, et al. Obesity is a positive modulator of IL-6R and IL-6 expression in the subcutaneous adipose tissue: significance for metabolic inflammation [J]. PLoS One, 2015, 10: e0133494.
[21] Jorgensen SB, O'Neill HM, Sylow L, et al. Deletion of skeletal muscle SOCS3 prevents insulin resistancein obesity [J]. Diabetes, 2013, 62(1): 56-64.
[22] Gallo D, Gesmundo I, Trovato L, et al. GH-releasing hormone promotes survival and prevents TNF-α-induced apoptosis and atrophy in C2C12 myotubes [J]. Endocrinology, 2015, 156(9): 3239-3252.
[23] Hall DT, Ma JF, Marco SD, et al. Inducible nitric oxide synthase (iNOS) in muscle wasting syndrome, sarcopenia, and cachexia [J]. Aging (Albany NY), 2011, 3(8): 702-715.
[24] Fanzani A, Conraads VM, Penna F, et al. Molecular and cellular mechanisms of skeletal muscle atrophy: an update [J]. J Cachexia Sarcopenia Muscle, 2012, 3(3): 163-179.
[25] Schiaffino S, Dyar KA, Ciciliot S, et al. Mechanisms regulating skeletal muscle growth and atrophy [J]. FEBS J, 2013, 280(17): 4294-4314.
[26] Sabio G, Kennedy NJ, Kyros JC, et al. Role of muscle c-Jun NH2-terminal kinase 1 in obesity-induced insulinresistance [J]. Mol Cell Biol, 2010, 30(1): 106-115.
[27] Sishi B, Loos B, Ellis B, et al. Diet induced obesity alters signaling pathways and induces atrophy and apoptosis in skeletal muscle in a pre-diabetic rat model [J]. Exp Physiol, 2011, 96(2): 179-193.
[28] Hong E, Ko HJ, Cho YR, et al. Interleukin-10 prevents diet-induced insulin resistance by attenuating macrophage and cytokine response in skeletal muscle [J]. Diabetes, 2009, 58(11): 2525-2535.
[29] Liu Y, Sweeney G. Adiponectin action in skeletal muscle [J]. Best Pract Res Clin Endocrinol Metab, 2014, 28(1): 33-41.
[30] Iwabu M, Yamauchi T, Okada-Iwabu M, et al. Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca 2+ and AMPK/SIRT1 [J]. Nature, 2010, 464(4293): 1313-1319.
[31] Kwon H, Pessin JE. Adipokines mediate inflammation and insulin resistance [J]. Front Endocrinol, 2013, 4: 71.
[32] Duan XY, Xie PL, Ma YL, et al. Omentin inhibits osteoblastic differentiation of calcifying vascular smooth muscle cells through the PI3K/Akt pathway [J]. Amino Acids, 2011, 41(5): 1223-1231.
[33] Di MS, Cammas A, Lian XJ, et al. The translation inhibitor pateamine A prevents cachexiainduced muscle wastingin mice [J]. Nat Commun, 2012, 3: 896.
[34] Khan IM, Dai Perrard XY, Perrard JL, et al. Attenuated adipose tissue and skeletal muscle inflammation inobese mice with combined CD 4 + and CD 8 + T cell deficiency [J]. Atherosclerosis, 2014, 233(2): 419-428.
[35] Li Y, Xu S, Zhang X, et al. Skeletal intramyocellular lipid metabolism and insulin resistance [J]. Biophys Rep, 2015, 1(2): 90-98.
[36] Amati F, Dube JJ, Alvarez-Carnero E, et al. Skeletal muscle triglycerides, diacylglycerols, and ceramides in insulin resistance: another paradox in endurance-trained athletes? [J]. Diabetes, 2011, 60(10): 2588-2597.
[37] Jadhav KS, Dungan CM, Williamson DL. Metformin limits ceramide-induced senescence in C2C12 myoblasts [J]. Mech Ageing Dev, 2013, 134(11-12): 548-559.
[38] Unoki KH, Yamagishi S, Takeuchi M, et al. Pyridoxamine, an inhibitor of advanced glycation end product (AGE) formation ameliorates insulin resistance in obese, type 2 diabetic mice [J]. Protein Pept Lett, 2010, 17(9): 1177-1181.
[39] Daffu G, del Pozo CH, O'Shea KM, et al. Radical roles for RAGE in the pathogenesis of oxidative stress in cardiovascular diseases and beyond [J]. Int J Mol Sci, 2013, 14(10): 19891-19910.
[40] Wang Z, Li H, Zhang D, et al. Effect of advanced glycosylation end products on apoptosis in human adipose tissuederived stem cells in vitro [J]. Cell Biosci, 2015, 5: 3.
[41] Frost R, Lang CH. mTOR signaling in skeletal muscle during sepsis and inflammation: where does it all go wrong? [J]. Physiology, 2011, 26(2): 83-96.
[42] Schakman O, Kalista S, Barbe C, et al. Glucocorticoid-induced skeletal muscle atrophy [J]. Int J Biochem Cell Biol, 2013, 45(10): 2163-2172.
[43] Patel R, Williams DJ, Cummins CL. Mini review: new molecular mediators of glucocorticoid receptor activity in metabolic tissues [J]. Mol Endocrinol, 2014, 28(7): 999-1011.
[44] Jeong JY, Jeoung NH, Park K, et al. Transcriptional regulation of pyruvate dehydrogenase kinas [J]. Diabetes Metab J, 2013, 36(5): 328-335.
[45] Lee MJ, Pramyothin P, Karastergiou K, et al. Deconstructing the roles of glucocorticoids in adipose tissue biology and the development of central obesity [J]. Biochim Biophys Acta, 2014, 1842(3): 473-481.
[46] Mitsuishi M, Miyashita K, Muraki A, et al. Angiotensin II reduces mitochondrial content in skeletal muscle and affects glycemic control [J]. Diabetes, 2009, 58(3): 710-717.
[47] Yoshida T, Tabony AM, Galvez S, et al. Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia [J]. Int J Biochem Cell Biol, 2013, 45(10): 2322-2332.
[48] Clasen BF, Poulsen MM, Escande C, et al. Growth hormone signaling in muscle and adipose tissue of obese human subjects: associations with measuresof body composition and interaction with resveratrol treatment [J]. J Clin Endocrinol Metab, 2014, 99(112): E2565-E2573.
[49] Enns DL, Tiidus PM. The influence of estrogen on skeletal muscle: sex matters [J]. Sports Med, 2010, 40(1): 41-58.
[50] Cipriani C, Pepe J, Piemonte S, et al. Vitamin D and its relationship with obesity and muscle [J]. Int J Endocrinol, 2014, 2014: 841248.

Advances of Molecular Mechanisms on Obesity Inducing Muscle Atrophy (review)

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Metrics

Comments

Recommended 0

[1]	SHAO Weiting, LEI Jianghua. Effect of response interruption and redirection as a behavioral intervention on vocal stereotypy in children with autism spectrum disorder: a scoping review [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2024, 30(1): 10-20.
[2]	WANG Hangyu, GE Keke, FAN Yonghong, DU Lilu, ZOU Min, FENG Lei. Effect of active music therapy on cognitive function for older adults with cognitive impairment: a systematic review based on ICD-11 and ICF [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2024, 30(1): 36-43.
[3]	WEN Jianing, JIN Qiuyan, ZHANG Qi, LI Jie, SI Qi. Effect of cognitively engaging physical activity on developing executive function of children and adolescents: a systematic review based on ICF [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2024, 30(1): 44-53.
[4]	GE Keke, FAN Yonghong, WANG Hangyu, DU Lilu, LI Changjiang, ZOU Min. Health benefit of mindfulness intervention for older adults with insomnia disorders: a systematic review [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2024, 30(1): 54-60.
[5]	ZHANG Jingya, ZOU Min, SUN Hongwei, SUN Changlong, ZHU Juntong. Effect of psychological intervention on anxiety or depression in children and adolescents with hearing impairment: a systematic review [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2023, 29(9): 1004-1011.
[6]	WANG Junyu, YANG Yong, YUAN Xun, XIE Ting, ZHUANG Jie. Effect of high-intensity interval training on executive function for healthy children and adolescents: a systematic review [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2023, 29(9): 1012-1020.
[7]	WEI Xiaowei, YANG Jian, WEI Chunyan. Psychological and behavioral benefits of adapted yoga exercise for children with autism spectrum disorder in special education schools: a systematic review [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2023, 29(9): 1021-1028.
[8]	YANG Yaru, YANG Jian. School-based physical activity-related health services and their health benefits within the World Health Organization health-promoting school framework: a systematic review of systematic reviews [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2023, 29(9): 1040-1047.
[9]	WANG He, HAN Liang, KAN Mengfan, YU Shaohong. Efficacy of electrical stimulation on shoulder-hand syndrome after stroke: a systematic review and meta-analysis [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2023, 29(9): 1048-1056.
[10]	SHI Jiawei, LI Lingyu, YANG Haojie, WANG Qinlu, ZOU Haiou. Effect of preoperative prerehabilitation training on total knee arthroplasty: a systematic review of systematic reviews [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2023, 29(9): 1057-1064.
[11]	JIANG Changhao, HUANG Chen, GAO Xiaoyan, DAI Yuanfu, ZHAO Guoming. Effect of neurofeedback training on cognitive function in the elderly: a systematic review [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2023, 29(8): 903-909.
[12]	WEI Xiaowei, YANG Jian, WEI Chunyan, HE Qiling. Adapted physical education programs for psychomotor development in school settings for children with intellectual and developmental disabilities: a systematic review [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2023, 29(8): 910-918.
[13]	ZHANG Yuan, YANG Jian. School health services and effectiveness based on World Health Organization health-promoting school framework: a scoping review [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2023, 29(7): 791-799.
[14]	WANG Shaopu, CHEN Gang. Psychological-behavioral health services and its outcome based on World Health Organization health-promoting school framework: a systematic review of systematic reviews [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2023, 29(7): 800-807.
[15]	JIANG Changhao, GAO Xiaoyan. Effect of acute physical activity on cognitive function in children: a systematic review [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2023, 29(6): 667-672.